1、 2020 Questex Content Marketing.All rights reserved.All registered trademarks are property of their respective owners.PRESENTED BY:WHITE PAPERPUBLISHED BY:Digital therapeutics:How cloud technology is enhancing patient experience and outcomesDigital therapeutics are becoming an increasingly important

2、 tool for how life sciences companies bring products to market.Investors and pharma companies alike are entering the sector,attracted by mounting evidence that digital technologies drive clinically meaningful improvements in patient outcomes.New entrants,like the pioneers before them,are learning pa

3、tient-facing digital therapeutics are only part of the solution in supporting the patient journey.To succeed,companies also need a secure,scalable and interoperable system for handling large volumes of potentially sensitive patient data.The amount of data generated from biosensors,wearables and mobi

4、le devices will continue to accelerate.The definition of digital therapeutics encompasses several subcategories.Smart pills and connected inhalers support pharmacological interventions by improving adherence and generating insights into patient behavior.Companion apps leverage mobile technology to e

5、nhance the patient experience through coaching,feedback on their condition,and actionable insights.Researchers have validated the effectiveness of such interventions.A randomized clinical trial of Propeller Healths digital health platform for asthma and COPD linked the combination to a significant d

6、rop in use of short-acting b-agonists and improved asthma control.1 Standalone digital therapeutics can improve health outcomes independently of drug regimens.Researchers found that Omada Healths product reduced the risk of type 2 diabetes by 30%.2 Akili Interactive won FDA approval for its therapeu